The United Kingdom has announced that it will lift travel restrictions for those who are fully vaccinated against COVID-19 with vaccines that are given Emergency Use Authorisation (EUA) by World Health Organisation. Those travellers who are fully vaccinated with WHO authorised vaccine can now enter the UK without undergoing any self-isolation. The advisory will be followed from November 22.
Alex Ellis, British High Commissioner to India tweeted, “More good news for travellers to From 22 November travellers fully vaccinated with a COVID19 vaccine recognised by WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield.”
More good news for 🇮🇳 travellers to 🇬🇧👇
From 22 November travellers fully vaccinated with a #COVID19 vaccine recognised by @WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield.https://t.co/UyJsryBd0O https://t.co/mZhaqRgB35— Alex Ellis (@AlexWEllis) November 8, 2021
The new rules will ease the movement of those who are inoculated with the vaccines under inoculated under the WHO’s Emergency Use Listings such as Covaxin which is India’s indigenous vaccine developed by Bharat Biotech. Other vaccines approved involves China’s Sinovac, Sinopharm, Pfizer-BioNTech, Johnson & Johnson, Moderna, Oxford-AstraZeneca, Covishield.
The WHO said in a tweet that the Technical Advisory Group, convened by World Health Organisation (WHO), has determined that the Hyderabad-based Bharat Biotech’s COVID-19 vaccine meets WHO standards for protection against COVID-19. “WHO has granted emergency use listing (EUL) to COVAXIN®[?] (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19,” WHO said in a tweet.
